Diffuse Intense 18F-PSMA-1007 Uptake of the Breasts in a Woman With TFE3-Rearranged Renal Cell Carcinoma

被引：1
|
作者：
Zhao, Qian [1 ]
Dong, Aisheng [2 ,3 ]
Zuo, Changjing [2 ,3 ]
机构：
[1] Ningxia Med Univ, Gen Hosp, Dept Nucl Med, Yinchuan, Ningxia, Peoples R China
[2] Naval Med Univ, Affiliated Hosp 1, Dept Nucl Med, Shanghai, Peoples R China
[3] Changhai Hosp, Dept Nucl Med, 168 Changhai Rd, Shanghai 200433, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2024年 / 49卷 / 07期
关键词：
breast; accessory breast; physiological uptake; TFE3-rearranged renal cell carcinoma; PSMA; PET/CT; GYNECOMASTIA; PSMA;
D O I：
10.1097/RLU.0000000000005260
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 23-year-old woman presenting with gross hematuria was found to have a left renal mass suspicious for renal cell carcinoma on abdominal contrast-enhanced CT. An F-18-PSMA-1007 PET/CT scan was performed for evaluating the renal mass. F-18-PSMA-1007 PET/CT showed focal activity of the renal mass, which was a transcription factor E3-rearranged renal cell carcinoma proved after nephrectomy. Surprisingly, diffuse heterogeneous intense activity of the bilateral breasts and moderate activity of the right accessory breast was observed. There was no morphological abnormality of the bilateral breasts and right accessory breast on CT images, indicating physiological PSMA uptake.
引用
收藏
页码：693 / 694
页数：2
相关论文
共 50 条
  • [31] COVID-19-Related Lung Parenchymal Uptake on 18F-PSMA-1007 PET/CT
    Nawwar, Ayah A.
    Searle, Julie
    Green, Jes S.
    Lyburn, Iain D.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (12) : 1016 - 1017
  • [32] Establishment and Characterization of a TFE3-rearranged Renal Cell Carcinoma Cell Line (FU-UR-2) With the PRCC-TFE3 Fusion Transcript
    Ishiguro, Masako
    Fukushige, Tomoko
    Iwasaki, Hiroshi
    ANTICANCER RESEARCH, 2023, 43 (08) : 3463 - 3470
  • [33] Exploring TFE3-Rearranged Renal Cell Carcinoma: A Case Study showing minimal expression of PAX-8
    Sustache, J. M. Rivera
    Bhalla, R.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 162 : S143 - S143
  • [34] Comparison of PET/CT images with 18F-FDG and 18F-PSMA-1007 in relapsed adenoid cystic carcinoma
    Etchebehere, E.
    Sousa, H. S. V.
    Tobar, N.
    Macedo, L. T.
    Kuba, S.
    Santos, A. O.
    Amorim, B. J.
    Lima, C. S. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S868 - S868
  • [35] Comparison of the 18F-PSMA-1007 and 18F-FAPI-42 PET/ CT in the evaluation of prostate cancer and correlation between PSMA and FAPI uptake
    Mu, X.
    Li, M.
    Fu, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S536 - S536
  • [36] Detection of Diffuse Peritoneal and Omental Metastases From Prostate Cancer With 18F-PSMA-1007 PET/CT
    Ji, Xiaowei
    Wang, Ling
    Lin, Jie
    Tang, Kun
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : E74 - E76
  • [37] Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
    Hu, Yuan
    Wang, Peng
    Dai, Wenli
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [38] Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
    Yuan Hu
    Peng Wang
    Wenli Dai
    BMC Pulmonary Medicine, 23
  • [39] Comparison of biodistribution of 18F-PSMA-1007 and 68GaPSMA-11 in prostate carcinoma patients
    Rana, N.
    Tanwar, K.
    Singh, H.
    Mittal, B. R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S507 - S508
  • [40] 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy
    Mittlmeier, L.
    Unterrainer, M.
    Rodler, S.
    Todica, A.
    Albert, N. L.
    Burgard, C.
    Cyran, C. C.
    Kunz, W. G.
    Ricke, J.
    Bartenstein, P.
    Stief, C. G.
    Staehler, M.
    Ilhan, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S283 - S284
12345